Skip to main content

Advertisement

Log in

Neuro-oncology

Stability of medulloblastoma subgroups at tumour recurrence

  • News & Views
  • Published:

From Nature Reviews Neurology

View current issue Sign up to alerts

Medulloblastomas can be categorized into four molecular subgroups. A new report shows, for the first time, that these tumours remain in the same subgroup at relapse, and the molecular subgroup influences the pattern of relapse. These findings indicate that this developmentally defined classification is robust, although its relationship to prognosis remains uncertain.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1: Medulloblastoma subgroups and recurrence patterns.

References

  1. Grill, J. et al. Treatment of medulloblastoma with post-operative chemotherapy alone: an SFOP prospective trial in young children. Lancet Oncol. 6, 573–580 (2005).

    Article  CAS  PubMed  Google Scholar 

  2. Ramaswamy, V. et al. Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis. Lancet Oncol. 14, 1200–1207 (2013).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Northcott, P. A. et al. Subgroup-specific structural variation across 1,000 medulloblastoma genomes. Nature 488, 49–56 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Philips, H. S. et al. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9, 157–173 (2006).

    Article  Google Scholar 

  5. Sottoriva, A. et al. Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics. Proc. Natl Acad . Sci. USA 110, 4009–4014 (2013).

    Article  CAS  PubMed  Google Scholar 

  6. MacDonald, T. J. et al. Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathways as therapeutic targets for metastatic disease. Nat. Genet. 29, 143–152 (2001).

    Article  CAS  PubMed  Google Scholar 

  7. Peyre, M. et al. Portrait of ependymoma recurrence in children: biomarkers of tumor progression identified by dual-color microarray-based gene expression analysis. P LoS ONE 5, e12932 (2010).

    Article  Google Scholar 

  8. Merchant, T. E. et al. Conformal radiotherapy after surgery for paediatric ependymoma: a prospective study. Lan cet Oncol. 10, 258–266 (2009).

    Article  Google Scholar 

  9. Paugh, B. S. et al. Genome-wide analyses identify recurrent amplifications of receptor tyrosine kinases and cell-cycle regulatory genes in diffuse intrinsic pontine glioma. J. Clin. Onc ol. 29, 3999–4006 (2011).

    Article  CAS  Google Scholar 

  10. Puget, S. et al. Mesenchymal transition and PDGFRA amplification/mutation are key distinct oncogenic events in pediatric diffuse intrinsic pontine gliomas. PLoS ONE 7, e30313 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jacques Grill.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Cite this article

Grill, J., Dufour, C. Stability of medulloblastoma subgroups at tumour recurrence. Nat Rev Neurol 10, 5–6 (2014). https://doi.org/10.1038/nrneurol.2013.256

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneurol.2013.256

  • Springer Nature Limited

This article is cited by

Navigation